These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 8638849)

  • 1. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
    Yang HS; Goudsouzian N; Martyn JA
    Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reversal of profound mivacurium-induced neuromuscular blockade.
    Kao YJ; Le ND
    Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium.
    Fleming NW; Lewis BK
    Br J Anaesth; 1994 Aug; 73(2):241-3. PubMed ID: 7917744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
    Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
    Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
    Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
    Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neostigmine requirements for reversal of neuromuscular blockade following an infusion of mivacurium.
    Lessard MR; Trépanier CA; Rouillard JF
    Can J Anaesth; 1997 Aug; 44(8):836-42. PubMed ID: 9260011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery.
    Lien CA; Belmont MR; Wray Roth DL; Okamoto M; Abalos A; Savarese JJ
    Anesthesiology; 1999 Jul; 91(1):119-26. PubMed ID: 10422936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of the monitoring of curarisation during prolonged mivacurium induced neuromuscular block].
    Avargues P; Cros AM; Dardel E; Darriet M; Biteau N
    Ann Fr Anesth Reanim; 1995; 14(6):511-3. PubMed ID: 8745977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis.
    Hart PS; Wright PM; Brown R; Lau M; Sharma ML; Miller RD; Gruenke L; Fisher DM
    Anesthesiology; 1995 Apr; 82(4):912-8. PubMed ID: 7717563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism.
    McGehee DS; Krasowski MD; Fung DL; Wilson B; Gronert GA; Moss J
    Anesthesiology; 2000 Aug; 93(2):510-9. PubMed ID: 10910502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
    Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
    Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
    Hayes A; Breslin D; Reid J; Mirakhur RK
    Anaesthesia; 2000 Sep; 55(9):859-63. PubMed ID: 10947748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of edrophonium and neostigmine for the reversal of mivacurium-induced neuromuscular blockade in sheep.
    Clutton RE; Glasby MA
    Res Vet Sci; 1998; 64(3):265-6. PubMed ID: 9690616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium.
    Devcic A; Munshi CA; Gandhi SK; Kampine JP
    Anesth Analg; 1995 Nov; 81(5):1005-9. PubMed ID: 7486038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prolonged neuromuscular block after administration of mivacurium caused by plasma psueudocholinesterase deficiency].
    Kaiser E; Petit D; Quinot JF; Suppini A; Sallaberry M
    Ann Fr Anesth Reanim; 1995; 14(6):505-7. PubMed ID: 8745975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous recovery or evoked reversal of neuromuscular block.
    Mirakhur RK
    Acta Anaesthesiol Scand Suppl; 1995; 106():62-5. PubMed ID: 8533549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholinesterases].
    Lejus C; Blanloeil Y; Burnat P; Souron R
    Ann Fr Anesth Reanim; 1998; 17(9):1122-35. PubMed ID: 9835982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.